Among Persons With HIV, More Finish Short-Course TB Prophylaxis
Tuberculosis preventive treatment completion is higher with three months of rifapentine-isoniazid than six months of isoniazid among patients with HIV receiving antiretroviral therapy.
HIV/AIDS
Specific Gene Silencing Induces Apoptosis of HIV-Infected Macrophages
Investigators performed a genome-wide screening study to determine whether silencing specific genes induces apoptosis of HIV-infected macrophages.
Cabotegravir Bests TDF-FTC for HIV Prevention in Those at Risk
For men who have sex with men and transgender women, long-acting injectable cabotegravir, is superior to TDF-FTC for preventing HIV infection.
Lenacapavir NDA Submitted for HIV-1 in Heavily Treatment Experienced Patients
Lenacapavir is an investigational, long-acting HIV-1 capsid inhibitor designed to inhibit HIV replication at multiple stages of its lifecycle.
Understanding the Relationship Between Alzheimer Disease and HIV
Study researchers sought to differentiate between HIV-associated neurocognitive disorder and true Alzheimer disease in patients with HIV.
HIV Incidence Remains Low With PrEP in Real-World Setting
HIV incidence remains low over three years of follow-up among individuals at high risk of HIV receiving preexposure prophylaxis (PrEP).
Fighting the Syndemic: Addressing Opioid Use Disorder and Decreasing HIV Go Hand-in- Hand
Structural concerns, racial and socioeconomic issues, and state- and federal-level policy present challenges when trying to address the intersecting epidemics of opioid use disorder and HIV.
New HIV Infections in the US Continued to Decrease in 2019
Recently, the annual incidence of HIV infections has been on the decline, reaching 34,800 infections in 2019.
Dolutegravir, Emtricitabine, and Tenofovir Alafenamide Fumarate Associated With Fewest Negative Pregnancy Outcomes Among Women With HIV
IMPAACT and VESTED assessed pregnancy outcomes and viral suppression status for pregnant women with HIV undergoing treatment with antiretroviral agents.
Citrate and Succinate Levels Linked to Neurocognitive Impairment in Older Patients With HIV
By exploring links between fasting plasma citrate and succinate levels, researchers tested their hypothesis that a metabolic shift may contribute to neurocognitive impairment in people with HIV.
- Loading...
Loading...
Next post in Neurocognitive Disorders
Loading... 
Loading...